Search research articles
Contact Us
Filters
Showing results (71-80 of 97) with videos related to
Page
of 10
Sort By:
Journal of Experimental & Clinical Cancer Research : CR
|
October 27, 2022
LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer
Donatella Delle Cave, Silvia Buonaiuto, Bruno Sainz, et al.
Oncogene
|
April 3, 2019
Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance
Gabriele D'Errico, Marta Alonso-Nocelo, Mireia Vallespinos, et al.
Journal of Nanobiotechnology
|
December 24, 2024
Reprogramming tumor-associated macrophages with lipid nanosystems reduces PDAC tumor burden and liver metastasis
Adrián Palencia-Campos, Laura Ruiz-Cañas, Marcelina Abal-Sanisidro, et al.
Cancer Research Communications
|
September 3, 2024
Autofluorescent Cancer Stem Cells: Potential Biomarker to Predict Recurrence in Resected Colorectal Tumors
Sonia Alcala, Gonzalo Serralta San Martin, Marta Muñoz-Fernández de Legaria, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 21, 2018
Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors
Magdolna Djurec, Osvaldo Graña, Albert Lee, et al.
Cell Death & Disease
|
August 6, 2025
TGF-β1-mediated downregulation of L1CAM in pancreatic ductal adenocarcinoma drives upregulation of collagen 17A1 and MMP2, facilitating tumor invasiveness and metastasis
Donatella Delle Cave, Annalisa Di Domenico, Marco Fantuz, et al.
Cancers
|
April 30, 2021
Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study
Elisa Conde, Julie Earl, Lorena Crespo-Toro, et al.
United European Gastroenterology Journal
|
March 28, 2020
Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response
Pierre-Olivier Frappart, Karolin Walter, Johann Gout, et al.
Nature Communications
|
October 17, 2020
Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells
Sandra Valle, Sonia Alcalá, Laura Martin-Hijano, et al.
Cancer Letters
|
September 17, 2025
Aurora kinase A inhibition as a synthetic lethality strategy in ARID1A-mutated gastroenteropancreatic neuroendocrine carcinoma
Maria Urbanova, Fabrice Viol, Laura Ruiz-Cañas, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 97) with videos related to
Sort By:
Page
of 10
Journal of Experimental & Clinical Cancer Research : CR
|
October 27, 2022
LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer
Donatella Delle Cave, Silvia Buonaiuto, Bruno Sainz, et al.
Oncogene
|
April 3, 2019
Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance
Gabriele D'Errico, Marta Alonso-Nocelo, Mireia Vallespinos, et al.
Journal of Nanobiotechnology
|
December 24, 2024
Reprogramming tumor-associated macrophages with lipid nanosystems reduces PDAC tumor burden and liver metastasis
Adrián Palencia-Campos, Laura Ruiz-Cañas, Marcelina Abal-Sanisidro, et al.
Cancer Research Communications
|
September 3, 2024
Autofluorescent Cancer Stem Cells: Potential Biomarker to Predict Recurrence in Resected Colorectal Tumors
Sonia Alcala, Gonzalo Serralta San Martin, Marta Muñoz-Fernández de Legaria, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 21, 2018
Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors
Magdolna Djurec, Osvaldo Graña, Albert Lee, et al.
Cell Death & Disease
|
August 6, 2025
TGF-β1-mediated downregulation of L1CAM in pancreatic ductal adenocarcinoma drives upregulation of collagen 17A1 and MMP2, facilitating tumor invasiveness and metastasis
Donatella Delle Cave, Annalisa Di Domenico, Marco Fantuz, et al.
Cancers
|
April 30, 2021
Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study
Elisa Conde, Julie Earl, Lorena Crespo-Toro, et al.
United European Gastroenterology Journal
|
March 28, 2020
Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response
Pierre-Olivier Frappart, Karolin Walter, Johann Gout, et al.
Nature Communications
|
October 17, 2020
Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells
Sandra Valle, Sonia Alcalá, Laura Martin-Hijano, et al.
Cancer Letters
|
September 17, 2025
Aurora kinase A inhibition as a synthetic lethality strategy in ARID1A-mutated gastroenteropancreatic neuroendocrine carcinoma
Maria Urbanova, Fabrice Viol, Laura Ruiz-Cañas, et al.
Page
of 10